Glenmark Pharmaceuticals informs about compliance certificate

16 Dec 2019 Evaluate

Glenmark Pharmaceuticals has informed that the Baddi manufacturing unit of the company was inspected by the leading European regulator, SUKL (State Institute for Drug control), Czech Republic in the week of October 21, 2019. The European regulator has just issued a certificate of compliance for the facility stating that it complies with the principles and guidelines of Good Manufacturing Practice laid down in the directive 2003/94/EC which stipulates the requirements to fulfill GMP recommendations of WHO. 

The above information is a part of company’s filings submitted to BSE.

Glenmark Pharma Share Price

1009.85 -0.75 (-0.07%)
15-May-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1528.20
Dr. Reddys Lab 5872.35
Cipla 1405.95
Zydus Lifesciences 997.45
Lupin 1638.40
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.